Creating a database for mediastinal tumors at Peking Union Medical College Hospital
A Single-center, Prospective, and Observational Study on Population Characteristics, Pathological Features, and Prognostic Factors of Patients With Mediastinal Tumor: Establishing Mediastinal Tumor Database of PUMCH.
This study is creating a database to help doctors better understand and treat different types of mediastinal tumors by collecting information on their characteristics and imaging results.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2000 (estimated) |
| Sex | All |
| Sponsor | Peking Union Medical College Hospital Academic / other |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Trial ID | NCT06421805 on ClinicalTrials.gov |
What this trial studies
This observational study aims to document the characteristics, imaging findings, and pathological features of patients with various mediastinal tumors, including thymic epithelial tumors and teratomas. By establishing a comprehensive database, the study seeks to enhance the quality of diagnosis and treatment protocols for these tumors. The collected clinical information will support medical decision-making and improve understanding of the complex nature of mediastinal tumors, which are often challenging to diagnose and treat due to their rarity and diversity.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals with a clinical or pathological diagnosis of mediastinal tumors.
Not a fit: Patients without complete clinicopathological information may not benefit from this study.
Why it matters
Potential benefit: If successful, this database could lead to improved diagnosis and treatment strategies for patients with mediastinal tumors.
How similar studies have performed: Previous tumor registration databases in North America and Europe have shown success in improving patient outcomes and treatment standards.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Clinical or pathological diagnosis of mediastinal tumors; 2. Written consent is able to obtained. Exclusion Criteria: 1\. Incomplete clinicopathological information.
Where this trial is running
Beijing, Beijing Municipality
- Peking Union Medical College Hospital — Beijing, Beijing Municipality, China (Recruiting)
Study contacts
- Study coordinator: Xuehan Gao, MD
- Email: gaoxh1299@163.com
- Phone: +86 18801341299
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.